An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
XVIVO Perfusion
315 participants
Oct 29, 2019
OBSERVATIONAL
Conditions
Summary
The XVIVO Registry is to collect standard of care clinical data from "all-comers" who are transplanted with an EVLP lung treated with the XVIVO Perfusion System™ in order to assess the long-term performance of the device, and monitor device-related serious adverse events. In addition, 4 and 5-year UNOS registry data of the 126 subjects who received an EVLP transplant under the NOVEL and NOVEL Extension studies are provided as part of the long-term safety and quality of life data. In addition, 4 and 5-year UNOS registry data of the 126 subjects who received an EVLP transplant under the NOVEL and NOVEL Extension studies are provided as part of the long-term safety and quality of life data.
Eligibility
Inclusion Criteria1
- This is an "All Comers Registry" hence will include all patients receiving EVLP lungs.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
XVIVO Perfusion System (XPS™) with STEEN Solution™
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05101460